ENDOMED AS
Score · fiscal year 2025
63of 100
How to read this: the company is ahead of 77 % of small companies in the same sector in 2025. What does this mean?
Rank: 8,964 of 38,671 · Handel
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 84 and solidity 51 out of 100 among small companies in the same sector in 2025. Methodology
Against the sector
ENDOMED AS is 13 points above the median for small companies in the same sector in 2025.
Median score 50 among 36,111 companies.
Against small companies in the same sector in 2025: operating margin 11.6% (median 2.5%) and equity ratio 46.3% (median 38.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 31 MNOK | 3 MNOK |
| Operating margin | 11.6% | 2.5% |
| Profit margin | 10.9% | 2.2% |
| Return on assets | 31.9% | 4.0% |
| Equity ratio | 46.3% | 38.3% |
| Debt-to-equity | 1.16 | 0.99 |
| Current ratio | 1.85 | 1.70 |
| Revenue growth | 3.3% | 3.5% |
The median and “ahead of” refer to small companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 63, ENDOMED AS does better than 77% of small companies in the same sector (36,580 companies) in 2025.
Score 2023–2025
- ENDOMED AS
- Median: small companies in the same sector
ENDOMED AS has a score of 63 for 2025, rank 8,964 of 38,671 in the sector.
Strongest: Profitability: percentile 84 against peers, operating margin 11.6% against a median of 2.5%. Consistency: percentile 66 against peers.
No area is clearly below its peers.
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
ENDOMED AS had an operating margin of 11.6% and an equity ratio of 46.3% in 2025, and ranks 8,964 of 38,671 in Handel.
From 2024 to 2025: the operating margin fell from 14.9% to 11.6% and the equity ratio rose from 40.3% to 46.3%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 5 MNOK and 32 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 26 MNOK |
| EV/EBIT | 8.0 | 32 MNOK |
| P/B | 1.0 | 5 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 4.7% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2017, the sector's weakest year, for this company.
The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 84 | weight 30% |
|---|---|---|
| Solidity | 51 | weight 25% |
| Liquidity | 54 | weight 15% |
| Growth | 50 | weight 15% |
| Consistency | 66 | weight 15% |
Durability: 63 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is ENDOMED AS?
The operating margin was 11.6% in 2025, against a median of 2.5% among small companies in the same sector. Return on assets was 31.9%.
How solid is ENDOMED AS?
The equity ratio was 46.3% in 2025 (median 38.3%). Debt-to-equity was 1.16 (median 0.99).
What is the liquidity of ENDOMED AS like?
The current ratio was 1.85 in 2025 (median 1.70).
How does ENDOMED AS compare in Handel?
ENDOMED AS ranks 8,964 of 38,671 in Handel for 2025. Among companies of the same size (small companies) it ranks 8,411 of 36,580. Revenue changed by 3.3% from the year before.
From the Central Coordinating Register
- Org. no.
- 813165082
- Legal form
- AS
- Sector
- Handel (46.460)
- Size tier
- small
- Employees
- 0–4 (not registered)
- Founded
- 29 October 1976 50 years in operation
- Share capital
- 1.25 MNOK
- Business address
- Professor Birkelands vei 34B, 1081 OSLO
- Municipality
- Oslo rank 106–282 of 357 in Norway
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Trygve Steinar Gammelsæter
- Chair of the board
- Joachim Christian Meinich Frich
- Board member
- Trygve Steinar Gammelsæter
- Auditor
- KROGH REVISJON AS
- Accountant
- AS SOLREGN
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 26 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 63 | 63 | 63 | |
| Rank | 9,577 | 8,938 | 8,964 | |
| Operating margin | 8.8% | 14.9% | 11.6% | |
| Return on assets | 25.1% | 36.3% | 31.9% | |
| Equity ratio | 46.0% | 40.3% | 46.3% | |
| Current ratio | 1.84 | 1.67 | 1.85 | |
| Revenue growth | – | 8.6% | 3.3% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 27.8 MNOK | 30.2 MNOK | 31.2 MNOK |
| Operating profit | 2.4 MNOK | 4.5 MNOK | 3.6 MNOK |
| Profit before tax | 2.2 MNOK | 4.3 MNOK | 3.4 MNOK |
| Net profit | 1.7 MNOK | 3.4 MNOK | 2.6 MNOK |
| Financial expenses | 0.4 MNOK | 0.2 MNOK | 0.3 MNOK |
| Total assets | 10.2 MNOK | 12.6 MNOK | 11.5 MNOK |
| Current assets | 10.1 MNOK | 12.5 MNOK | 11.5 MNOK |
| Equity | 4.7 MNOK | 5.1 MNOK | 5.3 MNOK |
| Retained earnings | 3.4 MNOK | 3.8 MNOK | 4.1 MNOK |
| Total liabilities | 5.5 MNOK | 7.5 MNOK | 6.2 MNOK |
| Current liabilities | 5.5 MNOK | 7.5 MNOK | 6.2 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 26 October 2026, accounts id 6690732.
Further
Similar companies
- ALESKA VED AS index 63, rank 8,965 · compare
- MONS SEMSHAUG AS index 63, rank 8,966 · compare
- KVERNELAND INFORMASJONSTEKNOLOGI OG FORRETNINGSUTVIKLING AS index 63, rank 8,967 · compare
- HAZEL NORGE AS index 63, rank 8,968 · compare
- HELGELAND RETAIL AS index 63, rank 8,969 · compare